I think Fred is impressive. I think Fred is more experienced. These thoughts are derived from watching and listening and a bit of researching. It’s my opinion.
I also think the best thing that could happen for the company and shareholders is the whole shooting match be sold for a very pretty penny. Soonish.
MSB have had their trial design licence revoked, in my book. I’ve said before that without them (SI mainly) the company would not be here but their usefulness is exhausted and they are the albatross around the companies neck.
They can ‘continue to learn’ how to spent large amounts of money. Their best is behind them. Imo.
Feel free to use any of my stuff in your communication with them. Lol.
Deadline for Novartis, page-223
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
97.0¢ |
Change
-0.005(0.51%) |
Mkt cap ! $1.107B | |||
| Open | High | Low | Value | Volume |
| 98.5¢ | 98.5¢ | 96.0¢ | $2.168M | 2.226M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 16000 | 96.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 97.0¢ | 86854 | 7 |
View Market Depth
| Last trade - 16.10pm 23/08/2024 (20 minute delay) ? |
| MSB (ASX) Chart |